Neonatal cardiomyopathies and metabolic crises due to oxidative phosphorylation defects

Area of Science:

• Biochemistry
• Genetics
• Neonatal Medicine

Background:

• Neonatal cardiomyopathies stem from mitochondrial oxidative phosphorylation (OXPHOS) defects, presenting as isolated or multi-organ conditions.
• Profound lactic acidosis is a hallmark, with hypertrophic cardiomyopathy being more common than dilated.
• Prenatal signs include fetal cardiomyopathy, arrhythmia, and hydrops, indicating early-onset severity.

Purpose of the Study:

• To elucidate the complex pathophysiology of neonatal cardiomyopathies caused by OXPHOS defects.
• To highlight the critical metabolic shift at birth impacting myocardial ATP production.
• To emphasize the need for standardized diagnostic procedures for accurate identification and genetic counseling.

Main Methods:

• Review of existing literature on neonatal cardiomyopathies and OXPHOS defects.
• Analysis of pathophysiological mechanisms, including myocardial energy metabolism.
• Discussion of diagnostic approaches and genetic testing.

Main Results:

• OXPHOS defects lead to severe neonatal heart conditions, often presenting with lactic acidosis.
• Cardiomyopathy type is predominantly hypertrophic.
• Pathophysiology involves more than just ATP deficiency, with heart specificity influenced by defect localization and genetic interactions.

Conclusions:

• Standardized diagnostic protocols are essential for confirming OXPHOS defects and identifying causal mutations.
• Accurate diagnosis enables crucial genetic counseling and potential prenatal diagnosis for affected families.
• Limited therapeutic options underscore the importance of early and precise diagnosis.